Yi Chen
Stock Analyst at HC Wainwright & Co.
(2.01)
# 2,962
Out of 4,883 analysts
501
Total ratings
37.8%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLTE Belite Bio | Reiterates: Buy | $100 | $59.47 | +68.17% | 20 | Jul 3, 2025 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $7 → $5 | $0.90 | +455.56% | 6 | Jul 1, 2025 | |
| ZYXI Zynex | Reiterates: Buy | $8 | $2.40 | +233.33% | 23 | Jun 30, 2025 | |
| LPCN Lipocine | Reiterates: Buy | $8 | $3.10 | +158.06% | 3 | Jun 27, 2025 | |
| EDSA Edesa Biotech | Assumes: Buy | $5 | $2.08 | +140.38% | 1 | Jun 27, 2025 | |
| ELDN Eledon Pharmaceuticals | Assumes: Buy | $9 | $3.08 | +192.21% | 1 | Jun 18, 2025 | |
| EYPT EyePoint Pharmaceuticals | Reiterates: Buy | $22 | $9.72 | +126.34% | 22 | May 29, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $15 | $9.62 | +55.93% | 27 | May 29, 2025 | |
| ICCM IceCure Medical | Reiterates: Buy | $2.5 | $1.06 | +136.97% | 21 | May 29, 2025 | |
| NPCE NeuroPace | Initiates: Buy | $18 | $10.39 | +73.24% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $0.81 | +515.54% | 21 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $12 | $5.10 | +135.29% | 22 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.26 | +217.46% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $53 | $29.65 | +78.75% | 4 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $22.84 | +31.35% | 2 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $60 | $31.75 | +88.98% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $19.24 | +29.94% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.78 | +151.80% | 13 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $16.42 | +204.51% | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $13.88 | +8.07% | 18 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $12.50 | +12.00% | 9 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.17 | +183.91% | 18 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $10.03 | +288.83% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $32 | $19.00 | +68.42% | 14 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.74 | +237.84% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.37 | +196.74% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.36 | +120.59% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $9.58 | +67.01% | 10 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.66 | +157.51% | 19 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $2.89 | +315.22% | 4 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.85 | +252.94% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.28 | +261.01% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.85 | +250.88% | 16 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.23 | +116.72% | 19 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.92 | +225.70% | 13 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $8.74 | +289.02% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.61 | +394.56% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.43 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5,250 → $1,125 | $4.63 | +24,198.06% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.26 | +3,741.72% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.42 | +2,528.43% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.74 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $16.67 | +187.94% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $13.79 | +37.78% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.53 | - | 2 | Apr 16, 2020 | |
Belite Bio
Jul 3, 2025
Reiterates: Buy
Price Target: $100
Current: $59.47
Upside: +68.17%
Lexaria Bioscience
Jul 1, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $0.90
Upside: +455.56%
Zynex
Jun 30, 2025
Reiterates: Buy
Price Target: $8
Current: $2.40
Upside: +233.33%
Lipocine
Jun 27, 2025
Reiterates: Buy
Price Target: $8
Current: $3.10
Upside: +158.06%
Edesa Biotech
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $2.08
Upside: +140.38%
Eledon Pharmaceuticals
Jun 18, 2025
Assumes: Buy
Price Target: $9
Current: $3.08
Upside: +192.21%
EyePoint Pharmaceuticals
May 29, 2025
Reiterates: Buy
Price Target: $22
Current: $9.72
Upside: +126.34%
Ocular Therapeutix
May 29, 2025
Reiterates: Buy
Price Target: $15
Current: $9.62
Upside: +55.93%
IceCure Medical
May 29, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.06
Upside: +136.97%
NeuroPace
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $10.39
Upside: +73.24%
May 23, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $0.81
Upside: +515.54%
May 23, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $5.10
Upside: +135.29%
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.26
Upside: +217.46%
May 15, 2025
Maintains: Buy
Price Target: $51 → $53
Current: $29.65
Upside: +78.75%
May 13, 2025
Reiterates: Buy
Price Target: $30
Current: $22.84
Upside: +31.35%
May 12, 2025
Maintains: Buy
Price Target: $57 → $60
Current: $31.75
Upside: +88.98%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $19.24
Upside: +29.94%
May 5, 2025
Reiterates: Buy
Price Target: $7
Current: $2.78
Upside: +151.80%
May 5, 2025
Reiterates: Buy
Price Target: $50
Current: $16.42
Upside: +204.51%
May 2, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $13.88
Upside: +8.07%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $12.50
Upside: +12.00%
Apr 29, 2025
Reiterates: Buy
Price Target: $9
Current: $3.17
Upside: +183.91%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $10.03
Upside: +288.83%
Apr 17, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $19.00
Upside: +68.42%
Apr 11, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.74
Upside: +237.84%
Apr 9, 2025
Initiates: Buy
Price Target: $10
Current: $3.37
Upside: +196.74%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.36
Upside: +120.59%
Apr 7, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $9.58
Upside: +67.01%
Apr 4, 2025
Reiterates: Buy
Price Target: $12
Current: $4.66
Upside: +157.51%
Apr 4, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.89
Upside: +315.22%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.85
Upside: +252.94%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.28
Upside: +261.01%
Mar 28, 2025
Reiterates: Buy
Price Target: $10
Current: $2.85
Upside: +250.88%
Mar 25, 2025
Reiterates: Buy
Price Target: $7
Current: $3.23
Upside: +116.72%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $0.92
Upside: +225.70%
Mar 21, 2025
Reiterates: Buy
Price Target: $34
Current: $8.74
Upside: +289.02%
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.61
Upside: +394.56%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.43
Upside: -
Jun 10, 2024
Maintains: Buy
Price Target: $5,250 → $1,125
Current: $4.63
Upside: +24,198.06%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.26
Upside: +3,741.72%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.42
Upside: +2,528.43%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.74
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $16.67
Upside: +187.94%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $13.79
Upside: +37.78%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.53
Upside: -